Answers are grounded in this paper and cite their sources.
Current status of endocrine treatment for breast cancer is reviewed. Several new aromatase inhibitors as well as antiestrogens are being introduced for clinical trials. As different drugs within the same drug group may possess different biochemical actions, apart from being useful drugs for treatment of breast cancer, these drugs may also extend our knowledge about the endocrinology of breast cancer.
No takes yet. Share an insight, caveat, or question.
Per Eystein Lønning (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: